With the resolution, compounding pharmacies are no longer able to produce tirzepatide. And the FDA highlighted the point to ...

There’s a war brewing over blockbuster weight loss medications — and patients are now getting caught in the crossfire.

The FDA decision will enable Antag Therapeutics to initiate the clinical development of its lead candidate drug, a ...

with their GP’s approval. The ANSM said in a press release that the use of this type of drug as a treatment for obesity is restricted and can only be prescribed as a treatment by specialists ...

Only a fifth of large U.S. companies cover pricey GLP-1 weight-loss drugs like Wegovy and Zepbound in their health insurance ...

The stock is the best performer in Europe’s Stoxx 600 Health Care Index after obesity-drug ... strong since it was approved in the US a year ago to treat psoriasis. The drug is also available ...

The weight loss jab Mounjaro will soon be made available to nearly a quarter of a million NHS patients, according to ...

When you think of brain stimulating medtech, startups building wearables as therapeutics probably aren't the first thing that ...

Danish laboratory Novo Nordisk has announced the launch of its anti-obesity drug Wegovy ... need the treatment from a medical perspective. While the French agency has given its approval for ...

The prescription drug has been all over the news in the past couple of years - but the name Ozempic has become something of a ...

Initially used to combat recurring Clostridium difficile (C. diff) infections, FMT boasts a success rate of over 90 per cent.

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.